Dr. David F. Claxton, MD

  • Lancaster, PA
  • Hematologist and oncologist
NPI1073562351
Medicare services, 2024
60
Medicare patients, 2024
17
Part D claims, 2024
31
Publications
107
Clinical trials
8
Practice address
555 N Duke St, Lancaster, PA 17602
Practice phone
Call (717) 544-5511
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Lancaster General Hospital

Lancaster, Pennsylvania

See all 4 affiliations

Find Dr. Claxton's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. David F. Claxton is a hematologist and oncologist in Lancaster, Pennsylvania

Dr. Claxton practices at Lancaster General Hospital in Lancaster, Pennsylvania.

Dr. Claxton's NPI, 1073562351, was assigned on May 6, 2006. Dr. Claxton holds Pennsylvania license MD070865L.

NPI and contact details
NPI enumeration date
May 6, 2006
NPI status
Active
Practice phone
(717) 544-5511
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
74
Medical school graduation
1978

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data

Dr. David F. Claxton practices at Lancaster General Hospital in Lancaster, Pennsylvania

Dr. Claxton's primary practice is Lancaster General Hospital, at 555 N Duke St, Lancaster, PA 17602 in Lancaster County. The practice phone is (717) 544-5511.

  • Lancaster General Hospital
    555 N Duke St, Lancaster, PA 17602 · Lancaster CountyPhone(717) 544-5511

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. David F. Claxton is affiliated with 2 sites of care and 2 medical groups

Dr. Claxton's primary practice is Lancaster General Hospital in Lancaster, Pennsylvania. Dr. Claxton is also affiliated with Penn State Health Milton S. Hershey Medical Center. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Claxton to 1 more medical group, named with a free account.

See all 4 affiliations for Dr. Claxton

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. David F. Claxton's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Claxton practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Lancaster General HospitalAvailable with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Claxton practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. David F. Claxton is one of 645 hematologists and oncologists in Pennsylvania

Hematology and oncology is Dr. Claxton's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Claxton is licensed in Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, PennsylvaniaPrimaryLicense MD070865L · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Claxton

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. David F. Claxton billed Medicare for 60 services in 2024

CMS data shows 60 Medicare services from Dr. Claxton across 2 procedure codes in 2024, for 17 Medicare patients. Medicare paid $4,362 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 202460
Medicare patients17
Paid by Medicare$4,362
Procedure codes2

Dr. Claxton's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1772024: 6066%

Dr. Claxton compared with the Pennsylvania median for hematologists and oncologists, 2024

  • Dr. Claxton
  • Pennsylvania median
Medicare services
60vs 65491% below
Medicare patients
17vs 22793% below
Part D claims
98vs 39375% below

Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Claxton's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Claxton

Need commercial claims for Dr. Claxton?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Claxton and other hematologists and oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. David F. Claxton treated 17 Medicare patients in 2024, average age 68

CMS counts 17 Medicare patients who saw Dr. Claxton in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Claxton's median patient age at 75, with 0% women.

Medicare patients, 202417
Average age68
Average risk score3.00

Dr. Claxton's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Claxton's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol71%

Share of Medicare patients with each condition. A patient can have several.

Dr. Claxton's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 75

Patient panel by sex, all payers

  • Women0%
  • Men100%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. David F. Claxton wrote 31 Medicare Part D claims in 2024

In 2024, Dr. Claxton wrote 31 Medicare Part D claims. 52% of them were for generic drugs. They cover 8 drugs, with $381,508 in total drug cost. In 2022, CMS named 502 claims across 28 drugs.

Part D claims, 202431
Drugs named by CMS8
Total drug cost$381,508

Dr. Claxton's Part D claims by kind of drug, 2024

  • Generic16 claims52%
  • Brand-name15 claims48%

Dr. Claxton's most prescribed drugs by claims, 2023

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2022 to 2023

  • 2022
  • 2023
Claims for drugs CMS names
2022: 5022023: 9880%

Drugs named by CMS: 8 in 2023, 28 in 2022.

See all prescribing by Dr. Claxton

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. David F. Claxton scored 79 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Claxton for performance year 2024, reported as part of a group.

Dr. Claxton's MIPS scores, performance year 2024

  • 79of 100Final score
  • 56.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 75of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Claxton by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. David F. Claxton has 107 publications on record

Dmand AI links 107 papers to Dr. Claxton, published from 2011 to 2025. 2018 was the busiest year, with 14. The most frequent topics are Leukemia, Myeloid, Acute, Hematopoietic Stem Cell Transplantation and Antineoplastic Agents. Dr. Claxton has published most often in Blood Adv. Dr. Claxton's most frequent co-authors are Thomas P. Loughran, MD, Shin Mineishi, MD and Seema Girish Naik, MD.

Papers107
Years published2011 to 2025

Dr. Claxton's papers by year, 2016 to 2025

Topics Dr. Claxton writes about most

  • Leukemia, Myeloid, Acute
  • Hematopoietic Stem Cell Transplantation
  • Antineoplastic Agents
  • Cell Line, Tumor
  • Apoptosis
  • Transplantation, Homologous
  • Cyclophosphamide
  • Graft vs Host Disease

Dr. Claxton's most frequent co-authors

Recent publications by Dr. Claxton

See all 107 publications and co-authors

See who Dr. Claxton researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Claxton works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. David F. Claxton has worked on 8 clinical trials

Dmand AI links Dr. Claxton to 8 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Burkitt Lymphoma. ECOG-ACRIN Cancer Research Group sponsors the most, 2. Open Payments lists research payments to Dr. Claxton that name 1 trial.

Clinical trials with Dr. Claxton by phase

  1. NonePhase 1: no trials
  2. 1Phase 1/2: 1 trial
  3. 2Phase 2: 2 trials
  4. 3Phase 3: 3 trials
  5. NonePhase 4: no trials

Conditions in Dr. Claxton's trials

  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid
  • Burkitt Lymphoma
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, Megakaryoblastic, Acute

Investigators on the most trials with Dr. Claxton

Recent clinical trials with Dr. Claxton

See all 8 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. David F. Claxton received $1,844 in industry payments from 2016 to 2021

CMS Open Payments shows 24 general payments to Dr. Claxton from 13 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 67% of the total. Pfizer Inc. paid the most, $242. It also lists 4 research payments totaling $1,970 in 2016, naming 1 clinical trial.

General payments to Dr. Claxton by program year, 2016 to 2021

General payments to Dr. Claxton by kind, 2016 to 2021

$1.8Kin total
  • Food and beverage$1,24167%
  • Education$60333%

Companies that paid Dr. Claxton the most, 2016 to 2021

Share is of all general payments to this clinician.

See all payments to Dr. Claxton

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. David F. Claxton's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesClinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. David F. Claxton

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. David F. Claxton's NPI number?

Dr. David F. Claxton's NPI number is 1073562351. It was assigned on May 6, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. David F. Claxton?

Dr. David F. Claxton is a hematologist and oncologist in Lancaster, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. David F. Claxton practice?

Dr. Claxton practices at 555 N Duke St, Lancaster, PA 17602. Dr. Claxton's primary practice is Lancaster General Hospital in Lancaster, Pennsylvania. Dmand AI also links Dr. Claxton to 1 medical group.

What is Dr. David F. Claxton's office phone number?

The practice phone on file for Dr. Claxton is (717) 544-5511.

What is Dr. David F. Claxton's medical license number?

Dr. Claxton holds Pennsylvania license MD070865L.

Which hospitals is Dr. David F. Claxton affiliated with?

Dr. Claxton is affiliated with Penn State Health Milton S. Hershey Medical Center.

What medical group is Dr. David F. Claxton part of?

Dr. Claxton is linked to Penn State Health Milton S. Hershey Medical Center. Dmand AI links Dr. Claxton to 1 more medical group.

Does Dr. David F. Claxton accept Medicare?

Yes. CMS data shows Dr. Claxton billed Medicare for 60 services in 2024.

What is Dr. David F. Claxton's MIPS score?

Dr. Claxton's MIPS final score for performance year 2024 is 79 out of 100, reported as part of a group.

How many Medicare patients does Dr. David F. Claxton see?

CMS counts 17 Medicare patients who saw Dr. Claxton in 2024, with an average age of 68.

Show 6 more questionsShow fewer questions

What services does Dr. David F. Claxton bill to Medicare?

In 2024, Dr. Claxton's most billed Medicare services were hospital inpatient care (99232) and hospital inpatient care (99233).

What drugs does Dr. David F. Claxton prescribe most?

In 2023 Medicare Part D data, Dr. Claxton's most prescribed drugs by claims were Sprycel, Lidocaine and Mycophenolate Mofetil.

Has Dr. David F. Claxton received payments from drug or device companies?

CMS Open Payments shows $1,844 in general payments to Dr. Claxton from 13 companies from 2016 to 2021. The largest total came from Pfizer Inc.

How long has Dr. David F. Claxton been practicing?

Dr. Claxton graduated from medical school in 1978, 48 years ago.

Does Dr. David F. Claxton do research?

Dmand AI links 107 publications to Dr. Claxton, published from 2011 to 2025. Dr. Claxton has worked on 8 clinical trials.

Who does Dr. David F. Claxton publish with?

Dr. Claxton's most frequent co-authors are Thomas P. Loughran, MD (24 shared papers), Shin Mineishi, MD (22 shared papers) and Seema Girish Naik, MD (16 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)